A randomized study of high-dose split course radiotherapy preceded by high-dose chemotherapy versus high-dose radiotherapy only in locally advanced non-small-cell lung cancer-Reference-Cited by-同舟云学术

A randomized study of high-dose split course radiotherapy preceded by high-dose chemotherapy versus high-dose radiotherapy only in locally advanced non-small-cell lung cancer

Published:1996-02 Issue:2 Volume:7 Page:139-144
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Planting A.,Helle P.,Drings P.,Dalesio O.,Kirkpatrick A.,McVie G.,Giaccone G.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/7/2/139/359100/7-2-139.pdf

Reference23 articles.

1. Non-small cell carcinoma of the lung: Dose time parameters;Perez;Cancer Treat Symp,1985

2. Lung cancer;Emami,1992

3. Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules;Gralla;Ann Intern Med,1981

4. Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small cell lung cancer;Klastersky;J Clin Oncol,1989

5. A randomized study of cisplatin versus cisplatin plus vindesine for non-small cell lung carcinoma;Kawahara;Cancer,1991

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic therapy‐based split‐course stereotactic body radiation therapy;Precision Radiation Oncology;2022-11-27

2. The Clinical Value of Computed Tomography (CT)-Guided 125I Brachytherapy for Locally Advanced Non-Small Cell Lung Cancer After Progression of Concurrent Radiochemotherapy;Cancer Management and Research;2021-07

3. Salvage treatment of NSCLC recurrence after first‐line chemotherapy failure: Iodine‐125 seed brachytherapy or microwave ablation?;Thoracic Cancer;2020-03

4. 125I Brachytherapy in Locally Advanced Nonsmall Cell Lung Cancer After Progression of Concurrent Radiochemotherapy;Medicine;2015-12

5. CT-guided implantation of radioactive 125I seed in advanced non-small-cell lung cancer after failure of first-line chemotherapy;Journal of Cancer Research and Clinical Oncology;2014-04-11